Julia M L Brotherton

Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study.

Deborah Bateson, Samuel Phillips, Bette Liu, 2014, The Lancet. Infectious diseases.

Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia

David C Whiteman, Annette J Dobson, Elizabeth Crowe, 2014, BMJ : British Medical Journal.

Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination

Samuel Phillips, S. Garland, M. Cummings, 2017, International journal of cancer.

Anaphylaxis following quadrivalent human papillomavirus vaccination

M. Gold, A. Kemp, J. Brotherton, 2008, Canadian Medical Association Journal.

Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis

Kate Soldan, Anne M Johnson, Marie-Claude Boily, 2015, BDJ.

Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: independent estimates from a nationally representative mobile phone survey.

Basil Donovan, Bette Liu, Bette C Liu, 2014, Vaccine.

Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000–2011

Karen Canfell, Peter Baade, Kamalini Lokuge, 2016, PloS one.